UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021				31,841,061	108,870,126
Beginning balance at Dec. 31, 2021	$ 225,542			$ 0	$ 1	$ 264,871	$ (230)	$ (39,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B Common Stock to Class A Common Stock (in shares)				10,842,862	(10,842,862)
Issuance of common stock upon exercise of stock options (in shares)				197,828
Issuance of common stock upon exercise of stock options	924					924
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares)				39,516
Issuance of common stock upon vesting of restricted stock units (in shares)				14,625
Stock-based compensation expense	932					932
Cumulative translation adjustment	(264)						(264)
Unrealized loss on investments	0
Net loss	(2,571)							(2,571)
Ending balance (in shares) at Mar. 31, 2022				42,935,892	98,027,264
Ending balance at Mar. 31, 2022	224,563			$ 0	$ 1	266,727	(494)	(41,671)
Beginning balance (in shares) at Dec. 31, 2022		43,743,000	97,844,000	43,743,174	97,843,570
Beginning balance at Dec. 31, 2022	199,904			$ 0	$ 1	274,057	(1,206)	(72,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B Common Stock to Class A Common Stock (in shares)				74,239,844	(74,239,844)
Conversion of Class B Common Stock to Class A Common Stock	$ 0			$ 1	$ (1)
Issuance of common stock upon exercise of stock options (in shares)	88,957			88,957
Issuance of common stock upon exercise of stock options	$ 67					67
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares)				38,879
Issuance of common stock in connection with Employee Stock Purchase Plan	264					264
Issuance of common stock upon vesting of restricted stock units (in shares)				71,557
Stock-based compensation expense	2,796					2,796
Cumulative translation adjustment	365						365
Unrealized loss on investments	(83)
Net loss	(9,860)							(9,860)
Ending balance (in shares) at Mar. 31, 2023		118,182,000	23,604,000	118,182,411	23,603,726
Ending balance at Mar. 31, 2023	$ 193,453			$ 1	$ 0	$ 277,184	$ (924)	$ (82,808)